003000.KS KSC
Bukwang Pharmaceutical Co., Ltd.
1W: +4.3%
1M: -6.4%
3M: -3.9%
YTD: -6.3%
1Y: +21.4%
3Y: -41.0%
5Y: -79.4%
₩4,100.00 ($3.05)
-55.00 (-1.32%)
Weekly Expected Move ±3.7%
₩3800
₩3950
₩4100
₩4250
₩4400
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$18.5B
-46.2% ▼
5Y CAGR: +91.2%
Capital Expenditures
$7.3B
-180.6% ▼
5Y CAGR: +30.3%
Free Cash Flow
$11.2B
-64.9% ▼
Dividends Paid
$4.9B
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$30.1B
+50.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $3.8B | -$1.0B | -$31.3B | -$3.0B | $12.6B |
| Depreciation & Amort. | $4.8B | $5.1B | $4.3B | $4.1B | $0 |
| Stock-Based Comp. | $3M | $44M | $0 | -$4M | $0 |
| Change in Working Capital | $18.9B | $7.2B | $23.8B | $24.6B | -$12.3B |
| Other Non-Cash Items | $1.1B | $5.2B | -$6.1B | $8.6B | $18.2B |
| Operating Cash Flow | $26.5B | $16.5B | -$9.4B | $34.4B | $18.5B |
| — Investing Activities — | |||||
| Capital Expenditures | -$790M | -$5.0B | -$2.8B | -$1.9B | -$11.3B |
| Acquisitions (Net) | -$3.0B | -$251M | $381M | $12.3B | $0 |
| Investment Purchases | -$6.6B | -$1.5B | -$1.9B | -$41.3B | $0 |
| Investment Sales | $14.8B | $3.1B | $1.2B | $3.9B | $0 |
| Other Investing | $388M | $503M | $874M | -$709M | -$84.4B |
| Investing Cash Flow | $4.7B | -$3.2B | -$2.3B | -$27.7B | -$95.7B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$20.0B | -$434M | $80.0B | -$63.6B | $0 |
| Stock Repurchased | -$516M | $0 | $0 | $0 | $0 |
| Dividends Paid | -$6.2B | -$6.8B | $0 | $0 | -$4.9B |
| Other Financing | -$743M | -$470M | -$3.2B | -$4.0B | -$459M |
| Financing Cash Flow | -$27.5B | -$10.4B | $76.8B | -$67.7B | $82.8B |
| Net Change in Cash | $3.5B | $2.7B | $65.7B | -$61.1B | -$30.1B |
| Cash End of Period | $82.8B | $85.5B | $151.2B | $90.1B | $0 |
| Free Cash Flow | $25.7B | $11.5B | -$13.3B | $31.7B | $11.2B |